Home Newsfeeds PMV Pharmaceuticals Q2 EPS $(0.38) Down From $(0.29) YoY

PMV Pharmaceuticals Q2 EPS $(0.38) Down From $(0.29) YoY

PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.38) per share. This is a 31.03 percent decrease over losses of $(0.29) per share from the same period last year.

byBenzinga Newsdesk

August 9, 2022

1 minute read

PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.38) per share. This is a 31.03 percent decrease over losses of $(0.29) per share from the same period last year.

Hong Kong Launches First $128M Crypto ETF Liquidity Fund

By Murtuza Merchant

May 8, 9:13 AM

Hong Kong’s burgeoning cryptocurrency market received a significant boost today with the announcement of its first-ever ETF liquidity fund.

BTC

Bitcoin, Ethereum, Dogecoin Drag As Investors’ Risk Appetite Cools: Analyst Sees Consolidation As Precursor To ‘Normal Bull Run’

By Aniket Verma

June 13, 9:57 PM

Leading cryptocurrencies slumped Thursday as the Federal Reserve's hawkish rate cut projection continued to fuel anxiety among investors.

$DOGE

Provident Financial Hldgs Q2 EPS $0.33 Misses $0.34 Estimate, Sales $10.34M Miss $10.40M Estimate

By Benzinga Newsdesk

January 27, 7:04 AM

Provident Financial Hldgs (NASDAQ:PROV) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.34 by 2.94 percent. This is a 10 percent increase over earnings of $0.30 per share

PROV